1BLACKSTEIN M,VOGEL CL,AMBINDE R,et al. Gemc- itabine as firstline therapy in patients with metastatic breast cancer: a phase trial[J]. Oncoloyg,2002,62(1):2-8.
2BRODOWICZ T, KOSTLER WJ, MOSLINGER R, et al. Single-agent gemcitabine as second-line and third-line treatment in metastatic breast cancer[J]. Breast,2000,9(6) : 338-342.
3X IE CY, X U YP, JIN W, et al. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer [J]. Anticancer Drug, 2012,23(7) :698-705.
